Use of fidaxomicin compared to vancomycin or metronidazole for initial treatment of clostridium difficile infection in a community hospital.

被引：0
|
作者：
Jacob, Bobby [1 ]
Shogbon, Angela O. [1 ]
Peasah, Samuel K. [2 ]
Bressler, Adam [3 ]
Vu, Michelle [1 ]
机构：
[1] Mercer Univ, Coll Pharm, Atlanta, GA USA
[2] Mercer Univ, Coll Pharm, Dept Pharm Practice, Atlanta, GA USA
[3] DeKalb Med Ctr, Decatur, GA USA
来源：
PHARMACOTHERAPY | 2016年 / 36卷 / 12期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
190
引用
收藏
页码：E250 / E251
页数：2
相关论文
共 50 条
  • [1] Fidaxomicin compared with vancomycin and metronidazole for the treatment of Clostridioides (Clostridium) difficile infection: A network meta-analysis
    Okumura, Hiroyuki
    Fukushima, Ayako
    Taieb, Vanessa
    Shoji, Shingo
    English, Marci
    JOURNAL OF INFECTION AND CHEMOTHERAPY, 2020, 26 (01) : 43 - 50
  • [2] Efficacy of Bezlotoxumab in Participants Receiving Metronidazole, Vancomycin, or Fidaxomicin for Treatment of Clostridioides (Clostridium) difficile Infection
    Dubberke, Erik R.
    Gerding, Dale N.
    Kelly, Ciaran P.
    Garey, Kevin W.
    Rahav, Galia
    Mosley, Audrey
    Tipping, Robert
    Dorr, Mary Beth
    OPEN FORUM INFECTIOUS DISEASES, 2020, 7 (06):
  • [3] Clinical and Economic Benefits of Fidaxomicin Compared to Vancomycin for Clostridium difficile Infection
    Gallagher, Jason C.
    Reilly, Joseph P.
    Navalkele, Bhagyashri
    Downham, Gemma
    Haynes, Kevin
    Trivedi, Manish
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2015, 59 (11) : 7007 - 7010
  • [4] A BUDGET IMPACT ANALYSIS OF FIDAXOMICIN VERSUS VANCOMYCIN AND METRONIDAZOLE FOR THE TREATMENT OF CLOSTRIDIUM DIFFICILE
    Leinwand, B.
    VALUE IN HEALTH, 2017, 20 (09) : A632 - A633
  • [5] COMPARATIVE EFFICACY OF FIDAXOMICIN, VANCOMYCIN AND METRONIDAZOLE FOR THE TREATMENT OF CLOSTRIDIUM DIFFICILE INFECTION: A NETWORK META-ANALYSIS
    Okumura, H.
    Fukushima, A.
    Taieb, V
    Shoji, S.
    English, M.
    VALUE IN HEALTH, 2018, 21 : S222 - S222
  • [6] Fidaxomicin versus Vancomycin for Clostridium difficile Infection
    Louie, Thomas J.
    Miller, Mark A.
    Mullane, Kathleen M.
    Weiss, Karl
    Lentnek, Arnold
    Golan, Yoav
    Gorbach, Sherwood
    Sears, Pamela
    Shue, Youe-Kong
    NEW ENGLAND JOURNAL OF MEDICINE, 2011, 364 (05): : 422 - 431
  • [7] Proteomic Signatures of Clostridium difficile Stressed with Metronidazole, Vancomycin, or Fidaxomicin
    Maass, Sandra
    Otto, Andreas
    Albrecht, Dirk
    Riedel, Katharina
    Trautwein-Schult, Anke
    Becher, Doerte
    CELLS, 2018, 7 (11)
  • [8] Treatment of First Recurrence of Clostridium difficile Infection: Fidaxomicin Versus Vancomycin
    Comely, Oliver A.
    Miller, Mark A.
    Louie, Thomas J.
    Crook, Derrick W.
    Gorbach, Sherwood L.
    CLINICAL INFECTIOUS DISEASES, 2012, 55 : S154 - S161
  • [9] Fidaxomicin versus Vancomycin in the Treatment of Clostridium difficile Infection: Canadian Outcomes
    Lee, Christine
    Louie, Thomas J.
    Weiss, Karl
    Valiquette, Louis
    Gerson, Marvin
    Arnott, Wendy
    Gorbach, Sherwood L.
    CANADIAN JOURNAL OF INFECTIOUS DISEASES & MEDICAL MICROBIOLOGY, 2016, 2016 : 1 - 8
  • [10] COST-EFFECTIVENESS OF FIDAXOMICIN VERSUS VANCOMYCIN AND METRONIDAZOLE IN PATIENTS WITH CLOSTRIDIUM DIFFICILE INFECTION IN SPAIN
    Watt, M.
    de Nigris, E.
    McCrea, C.
    VALUE IN HEALTH, 2017, 20 (09) : A784 - A784
12345